Touchlight Genetics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2016
- Posted on 7 October, 2016
SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held last night. The OBN Awards celebrate innovation and achievement across the UK life sciences industry, including emerging to late stage R&D companies as well as life science investors.
Touchlight Genetics, a London-based biotechnology company, has successfully established and patented a revolutionary enzymatic process of DNA amplification. Their success at the OBN Awards was attributed to the development of an innovative, in vitro dual enzyme process, capable of producing DNA at commercial scale and quality.
In sponsoring this award, we are supporting the growth of the UK’s burgeoning synthetic biology industry, a core aim of SynbiCITE.
The 3 finalist companies under consideration for this award were:
- Chain Biotech
- Green Biologics
- Touchlight Genetics
Share this article:
People also read
BBC highlight Modern Synthesis
Ben Reeve from Modern Synthesis and Tom Ellis from the Department of Bioengineering, Imperial College are featured on the One Show talking about the m...
BBC Click Combatting Cancer
BBC Click meets the scientists harnessing the power of robotics and AI to find new cancer treatments with fewer side effects. See James Field from Lab...
New Government report
UK Government report published this week entitled “Engineering Biology: Opportunities for the UK Economy and National Goals”, is an important document...